Roche Outlines Takeover Plan for Illumina Board | GenomeWeb

Roche last week outlined how it plans to gain a majority of Illumina's board of directors as part of its hostile takeover bid for the company.

At Illumina's 2012 annual meeting, expected to take place sometime this spring, the terms of four of the firm's nine directors will expire, and Roche will seek to fill these seats with four Roche-nominated candidates.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.